Correction to: Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy. . Circulation 2021;143:e744.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to: Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy. Circulation 2021;143:e744.
PMID: 33617317